Trials / Completed
CompletedNCT03129451
The Microbiome in Parkinson's Disease
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 23 (actual)
- Sponsor
- Corewell Health West · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
To investigate the dynamic relationship between the intestinal microbiota and Inflammation in subjects with Parkinson's disease.
Detailed description
To investigate the dynamic relationship between the intestinal microbiota and Inflammation in subjects with Parkinson's disease. The current study examines the differential microbiome of the gut in subjects with parkinsonism. The current study determines whether certain Parkinson's subtypes are prone to pro-inflammatory microbiomes. This study also explores whether the intestinal microbiome in post-appendectomy Parkinson's subjects is modified as appendix has a role in regulating intestinal microbiome. The current study will examine whether microbiome changes influence inflammatory markers in the blood.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Microbiome specimens in stool | Analyzing Microbiome specimens in stool |
Timeline
- Start date
- 2017-04-17
- Primary completion
- 2021-01-07
- Completion
- 2021-01-07
- First posted
- 2017-04-26
- Last updated
- 2024-04-08
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT03129451. Inclusion in this directory is not an endorsement.